Elevated plasma chemokine CCL18/PARC in β-thalassemia

Blood Cells, Molecules, and Diseases

Volumn 35, Issue 3, 2005, Pages 328-331

  Dimitriou, E ^a   Verhoek, M ^b   Altun, S ^b   Karabatsos, F ^a   Moraitou, M ^a   Youssef, J ^a   Boot, R ^b   Sarafidou, J ^a   Karagiorga, M ^a   Aerts, H ^b   Michelakakis, H ^a  

^a AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Thalassemia; CCL18 PARC; Chemokines

Indexed keywords

CCL 18 CHEMOKINE; CHEMOKINE; CHITOTRIOSIDASE; ENZYME; IRON CHELATING AGENT; PROTEIN PARC; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BETA THALASSEMIA; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME BLOOD LEVEL; GAUCHER DISEASE; GENOTYPE; HUMAN; IRON CHELATION; IRON OVERLOAD; LIPID STORAGE; NEWBORN; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THALASSEMIA MAJOR; WILD TYPE;

ADOLESCENT; ADULT; BETA-THALASSEMIA; CHEMOKINES, CC; CHILD; CHILD, PRESCHOOL; GAUCHER DISEASE; GREECE; HEXOSAMINIDASES; HUMANS; INFANT; INFANT, NEWBORN; MIDDLE AGED;

EID: 27744573062     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2005.07.006     Document Type: Article

References (17)

1. M. Baggiolini Chemokines and leucocyte traffic Nature 392 1998 565 568
2. T.E. Maione, G.S. Gray, J. Petro, A.J. Hunt, A.L. Donner, S.I. Bauer, H.G. Carson, and R.J. Sharpe Inhibition of angiogenesis by recombinant platelet factor-4 and related peptides Science 247 1990 77 79
3. H.E. Broxmeyer, and C.H. Kim Regulation of hematopoiesis in a sea of chemokine family members with a plethora of redundant activities Exp. Hematol. 27 1999 1113 1123
4. E. Schutyser, S. Struyf, P. Proost, G. Opdenakker, G. Laureys, B. Verhasselt, L. Peperstraete, I. Van de Putte, A. Saccani, P. Allavena, A. Mantovani, and J. Van Damme Identification of biologically active chemokine isoforms from ascitic fluid and elevated levels of CCL18/pulmonary and activation-regulated chemokine in ovarian carcinoma J. Biol. Chem. 277 2002 24584
5. G.J. Adema, F. Hartgers, R. Verstratey, E. de Vries, G. Marland, S. Menou, J. Foster, Y. Xu, P. Nooyen, T. McClanahan, K.B. Bacon, and C.G. Figdors A dentritic-cell derived C-C chemokine that preferentially attracts naïve T cells Nature 387 1997 713 717
6. K. Hieshima, T. Imai, M. Baba, K. Shoudai, K. Ishizuka, T. Nakagawa, J. Tsuruta, M. Takeya, Y. Sahaki, K. Takatsuki, R. Miura, G. Opdenakker, J. van Damme, O. Yoshie, and H. Nomiyama A novel human CC chemokine PARC that is most homologous to macrophage-inflammatory protein-1 alpha/LD78 alpha and chemotactic for T lymphocytes, but not for monocytes J. Immunol. 159 1997 1140 1149
7. R.G. Boot, M. Verhoek, M. de Fost, C.E.M. Hollak, M. Maas, B. Bleijlevens, M.J. van Breemen, M. van Meurs, L.A. Boven, J.D. Laman, M.T. Moran, T.M. Cox, and J.M.F.G. Aerts Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention Blood 103 2004 33 39
8. D.J. Weatherall, J.B. Clegg, D.R. Higgs, and W.G. Wood The hemoglobinopathies C.R. Scriver A.L. Beaudet W.S. Sly D. Valle B. Childs K.W. Kinzler B. Vogestein 8th ed. The Metabolic and Molecular Bases of Inherited Disease vol. III 2001 McGraw Hill New York 4571 4637
9. R. Barone, F. Di Gregorio, M.A. Romeo, G. Schiliro, and L. Pavone Plasma chitotriosidase activity in patients with β-thalassemia Blood Cells, Mol. Dis. 25 1998 2 9
10. G. Altarescu, B. Rudensky, A. Abrahamov, A. Goldfarb, D. Rund, A. Zimran, and D. Elstein Plasma chitotriosidase activity in patients with β-thalassemia Am. J. Hematol. 71 2002 7 10
11. C.E.M. Hollak, S. Van Weely, M.H.J. Van Oers, and J.M.F.G. Aerts Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease J. Clin. Invest. 93 1994 1288 1292
12. R.G. Boot, G.H. Renkema, M. Verhoek, A. Strijland, J. Bliek, T.M.A.M.O. de Meulemeester, M.M.A.M. Mannens, and J.M.F.G. Aerts The human chitotriosidase gene. Nature of inherited enzyme deficiency J. Biol. Chem. 273 1998 25680 25685
13. E. Beultler, and G.L. Grabowski Gaucher disease C.R. Scriver A.L. Beaudet W.S. Sly D. Valle B. Childs K.W. Kinzler B. Volgestein 8th ed. The Metabolic and Molecular Bases of Inherited Disease vol. VII 2001 McGraw Hill New York 3635 3669
14. G. Hodge, J.V. Lloyd, S. Hodge, C. Story, and P. Han Functional lymphocyte immunophenotypes observed in thalassaemia and hemophilia patients receiving current blood product preparations Br. J. Haematol. 105 1999 817 825
15. S. Romagnani The Th1/Th2 paradigm Immunol. Today 18 1997 263 266
16. L.A. Boven, M. van Meurs, R.G. Boot, A. Mehta, L. Boon, J.M. Aerts, and J.D. Laman Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages Am. J. Clin. Pathol. 122 2004 359 369
17. M.A. Blajchman, and J.O. Brodin Mechanism of transfusion associated immunosuppression Curr. Opin. Haematol. 1 1994 457 461